Logo image of LSDI

LUCY SCIENTIFIC DISCOVERY IN (LSDI) Stock Price, Forecast & Analysis

USA - NASDAQ:LSDI - CA54960E2033 - Common Stock

0.5139 USD
-0.16 (-23.29%)
Last: 6/28/2024, 8:12:35 PM
0.4552 USD
-0.06 (-11.42%)
After Hours: 6/28/2024, 8:12:35 PM

LSDI Key Statistics, Chart & Performance

Key Statistics
Market Cap904.46K
Revenue(TTM)16.70K
Net Income(TTM)-11300400
Shares1.76M
Float1.23M
52 Week High12.8
52 Week Low0.44
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-7.2
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2023-02-09
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


LSDI short term performance overview.The bars show the price performance of LSDI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

LSDI long term performance overview.The bars show the price performance of LSDI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of LSDI is 0.5139 USD. In the past month the price decreased by -40.24%. In the past year, price decreased by -95.53%.

LUCY SCIENTIFIC DISCOVERY IN / LSDI Daily stock chart

LSDI Latest News, Press Relases and Analysis

LSDI Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 42.63 887.25B
JNJ JOHNSON & JOHNSON 18.01 450.29B
AZN ASTRAZENECA PLC-SPONS ADR 18.87 259.73B
NVS NOVARTIS AG-SPONSORED ADR 14.14 245.02B
NVO NOVO-NORDISK A/S-SPONS ADR 11.86 206.66B
MRK MERCK & CO. INC. 9.74 214.26B
PFE PFIZER INC 7.77 141.29B
SNY SANOFI-ADR 11.32 120.61B
BMY BRISTOL-MYERS SQUIBB CO 7.11 94.91B
GSK GSK PLC-SPON ADR 7.81 94.73B
ZTS ZOETIS INC 18.86 52.99B
TAK TAKEDA PHARMACEUTIC-SP ADR 194.86 43.08B

About LSDI

Company Profile

LSDI logo image Lucy Scientific Discovery, Inc. operates as a psychotropics contract manufacturing company. The company is headquartered in Victoria, British Columbia. The company went IPO on 2023-02-09. The firm is engaged in researching, developing, and manufacturing psychotropic drugs. The firm is a manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies. The company is focused on developing therapies for patients in need, and through its lead candidate SANA-013, dedicated to advancing the understanding and applications of psychedelic medicine, improving mental health outcomes, and enhancing well-being for individuals worldwide. The firm is engaged in the production of a variety of natural, synthetic, and biosynthetic products to meet the needs of the psychotropics-based medicines market. Its products are in the form of raw materials, crude extracts, targeted formulations, single molecule fractions, and white- and private-label products.

Company Info

LUCY SCIENTIFIC DISCOVERY IN

301-1321 Blanshard Street

Victoria BRITISH COLUMBIA CA

Employees: 0

LSDI Company Website

Phone: 17784105195

LUCY SCIENTIFIC DISCOVERY IN / LSDI FAQ

Can you describe the business of LUCY SCIENTIFIC DISCOVERY IN?

Lucy Scientific Discovery, Inc. operates as a psychotropics contract manufacturing company. The company is headquartered in Victoria, British Columbia. The company went IPO on 2023-02-09. The firm is engaged in researching, developing, and manufacturing psychotropic drugs. The firm is a manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies. The company is focused on developing therapies for patients in need, and through its lead candidate SANA-013, dedicated to advancing the understanding and applications of psychedelic medicine, improving mental health outcomes, and enhancing well-being for individuals worldwide. The firm is engaged in the production of a variety of natural, synthetic, and biosynthetic products to meet the needs of the psychotropics-based medicines market. Its products are in the form of raw materials, crude extracts, targeted formulations, single molecule fractions, and white- and private-label products.


Can you provide the latest stock price for LUCY SCIENTIFIC DISCOVERY IN?

The current stock price of LSDI is 0.5139 USD. The price decreased by -23.29% in the last trading session.


Does LSDI stock pay dividends?

LSDI does not pay a dividend.


What is the ChartMill technical and fundamental rating of LSDI stock?

LSDI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Should I buy LSDI stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LSDI.


Can you provide the market cap for LUCY SCIENTIFIC DISCOVERY IN?

LUCY SCIENTIFIC DISCOVERY IN (LSDI) has a market capitalization of 904.46K USD. This makes LSDI a Nano Cap stock.


What is the ownership structure of LUCY SCIENTIFIC DISCOVERY IN (LSDI)?

You can find the ownership structure of LUCY SCIENTIFIC DISCOVERY IN (LSDI) on the Ownership tab.


LSDI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

LSDI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to LSDI. LSDI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LSDI Financial Highlights

Over the last trailing twelve months LSDI reported a non-GAAP Earnings per Share(EPS) of -7.2. The EPS decreased by -96.67% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -263.59%
ROE -13916.75%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-66.29%
Sales Q2Q%N/A
EPS 1Y (TTM)-96.67%
Revenue 1Y (TTM)N/A

LSDI Forecast & Estimates

7 analysts have analysed LSDI and the average price target is 35.7 USD. This implies a price increase of 6846.88% is expected in the next year compared to the current price of 0.5139.


Analysts
Analysts82.86
Price Target35.7 (6846.88%)
EPS Next Y78.1%
Revenue Next YearN/A

LSDI Ownership

Ownership
Inst Owners7.28%
Ins Owners65.53%
Short Float %N/A
Short RatioN/A